Individualization at the Heart of Comparative Effectiveness Research: The Time for i -CER Has Come

Abstract

Get full access to this article

View all access options for this article.

References

Neyman J.

Sur les applications de la théorie des probabilities aux experiences agaricales: essay des principle 1923. [English translation of excerpts by Dabrowska D, Speed T.]

Stat Sci. 1990; 5:463-72.

Fisher RA Design of Experiments. Edinburgh: Oliver and Boyd; 1935.

Orszag PR Health costs are the real deficit threat. Wall Street Journal . 15 May 2009. Available from: http://online.wsj.com/article/SB124234365947221489.html

Roy AD Some thoughts on the distribution of earnings. Oxford Econ Papers. 1951;3:135-46.

Rubin D. Bayesian inference for causal effects: the role of randomization. Ann Stat. 1978;6:34-58.

Stroup TS , McEvoy JP , Swartz MS , et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003;29(1):15-31.

Munkin MK , Trivedi PK Bayesian analysis of self-selection model with multiple outcomes using simulation-based estimation: an application to the demand for healthcare. J Econometrics. 2003;114:197-220.

Heckman JJ , Navarro S. Dynamic discrete choice and dynamic treatment effects. J Econometrics . 2007;136(2):341-96.

Florens JP , Heckman JJ , Meghir C. , Vytlacil E. Identification of treatment effects using control functions in models with continuous, endogenous treatment and heterogeneous effects. Econometrica. 2008;76(5):1191-206.

10.

Tunis SR , Stryer DB , Clancy CM Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. J Am Med Assoc. 203;290:1624-32.

11.

Cheng Y. , Berry DA Optimal adaptive randomized designs for clinical trials. Biometrika. 2007;94(3):673-89.

12.

Murphy SA An experimental design for the development of adaptive treatment strategies . Stat Med. 2005;24:1455-81.

13.

Senn S. Cross-Over Trials in Clinical Research. 2nd ed. Hoboken, NJ: Wiley; 2002.

14.

Stinnett AA , Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2 suppl):S65-80.

15.

Basu A. , Meltzer D. Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2): 112-27.